Dechra Pharmaceuticals PLC

OTCPK:DPHA.Y Stock Report

Market Cap: US$5.6b

Dechra Pharmaceuticals Future Growth

Future criteria checks 3/6

Dechra Pharmaceuticals is forecast to grow earnings and revenue by 62.5% and 7.9% per annum respectively. EPS is expected to grow by 89.8% per annum. Return on equity is forecast to be 19.8% in 3 years.

Key information

62.5%

Earnings growth rate

89.8%

EPS growth rate

Pharmaceuticals earnings growth23.7%
Revenue growth rate7.9%
Future return on equity19.8%
Analyst coverage

Low

Last updated03 Jan 2024

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

OTCPK:DPHA.Y - Analysts future estimates and past financials data (GBP Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
6/30/2026954187N/AN/A1
6/30/20259041231601825
6/30/20248371021421632
6/30/2023762-283364N/A
3/31/202374463975N/A
12/31/2022727404586N/A
9/30/20227044945105N/A
6/30/20226825845123N/A
3/31/20226616648121N/A
12/31/20216417351119N/A
9/30/2021624643104N/A
6/30/202160856-4589N/A
3/31/202158750-45102N/A
12/31/202056644-44114N/A
9/30/2020541397110N/A
6/30/20205153457106N/A
3/31/2020507315791N/A
12/31/2019499295776N/A
9/30/2019490305879N/A
6/30/2019482315982N/A
3/31/2019463286182N/A
12/31/2018444256281N/A
9/30/2018426305773N/A
6/30/2018407365164N/A
3/31/2018394405769N/A
12/31/2017381436375N/A
9/30/2017370356576N/A
6/30/2017359266777N/A
3/31/201733419N/A69N/A
12/31/201630911N/A62N/A
9/30/201627812N/A53N/A
6/30/201624813N/A44N/A
3/31/201623017N/A43N/A
12/31/201521320N/A42N/A
9/30/201520820N/A42N/A
6/30/201520319N/A41N/A
3/31/201520121N/A41N/A
12/31/201419922N/A42N/A
9/30/201419621N/A27N/A
6/30/201419419N/A11N/A
12/31/201319314N/A25N/A
9/30/201319113N/A31N/A
6/30/201318911N/A37N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: DPHA.Y is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.2%).

Earnings vs Market: DPHA.Y is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: DPHA.Y is expected to become profitable in the next 3 years.

Revenue vs Market: DPHA.Y's revenue (7.9% per year) is forecast to grow slower than the US market (8% per year).

High Growth Revenue: DPHA.Y's revenue (7.9% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: DPHA.Y's Return on Equity is forecast to be low in 3 years time (19.8%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y